MedTrace Logo

Optimizing Outcomes Using Suboxone for Opiate Dependence

NCT00591617 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 202

Last updated 2013-01-29

No results posted yet for this study

Summary

Building on a platform of pharmacological treatment with Suboxone (buprenorphine and naloxone), participants are randomly assigned to one of four psychosocial treatment conditions.

Conditions

  • Opioid Dependency

Interventions

OTHER

Psychosocial treatment plus Suboxone pharmacotherapy

Participants randomly assigned to one of four psychosocial treatment conditions building on pharmacotherapy with Suboxone (buprenorphine + naloxone)

Sponsors & Collaborators

Principal Investigators

  • Walter Ling, M.D. · UCLA Integrated Substance Abuse Programs

  • Maureen Hillhouse, Ph.D. · UCLA Integrated Substance Abuse Programs

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-09-30
Primary Completion
2012-01-31
Completion
2012-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00591617 on ClinicalTrials.gov